Industry: Pharmaceuticals, Biotechnology
Lpath, Inc., headquartered in San Diego, California, is a theranostics company focused on bioactive signaling lipids as targets for treating and diagnosing important human diseases. Lpath’s lead product candidate, SphingomabÔ, is a monoclonal antibody (mAb) against a validated cancer target, sphingosine-1-phosphate (S1P), and has demonstrated compelling results against six different forms of solid-tumor and blood-borne cancers in pre-clinical studies. Like Avastin® (Genentech’s enormously successful cancer drug), SphingomabÔ is anti- angiogenic, but SphingomabÔ has other mechanisms of action that may prove advantageous in the clinical ( www.lpath.com )
Lpath , Inc.
6335 Ferris Square Suite A
San Diego, California 92121
USA
Tel: (858) 678-0800
Fax: (858) 678-0900